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BronchiectasisAbstract Objectives: To assess whether there is a correlation between a proposed MDCT severity
score of bronchiectasis and pulmonary function tests.
Materials/methods: 20 patients presented with clinically or CT known bronchiectasis evaluated
clinically and with multidetector CT of the chest and relevant pulmonary function tests.
Results: By correlating severity of airway obstruction represented by the FEV1 severity (decreased
forced expiratory volume in one second) with our proposed CT score of bronchiectasis, we found
that CT score correlates with the severity of PFTs, and airflow obstruction in bronchiectasis which
is primarily linked to severity of extent of bronchiectasis, severity of bronchial wall thickening and
the degree of mosaic attenuation (the extent of decreased attenuation of lung parenchyma) which
implies an association of obliterative bronchitis with bronchiectasis. On the other hand there was
no statistically significant relationship between the severity of bronchial dilatation and FEV1. Also
there was no statistically significant relationship between the extent of mucous plugging in relation
to FEV1 severity.
Conclusions: MDCT is sensitive for showing, detecting, scoring and evaluating bronchiectasis, and
with the recent advances in MDCT, it becomes the modality of choice and the cornerstone in the
evaluation of bronchiectasis.
 2016 The Egyptian Society of Radiology andNuclearMedicine. Production and hosting by Elsevier B.V.
This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-
nd/4.0/).1. Introduction
Bronchiectasis is a chronic condition characterized by local
irreversible bronchial dilatation and is usually associated with
inflammation (1). Bronchiectasis is more common in women
than in men and is more frequently encountered in middle aged
414 R.M. Ibrahim et al.and elderly persons. The pathogenesis of bronchiectasis cannot
be explained by a single cause. The current model is a vicious
cycle of inflammation and altered response to infection. This
cycle depends not only on the type and virulence of the patho-
gen but also on the host immune response (2). The most com-
monly used classification of bronchiectasis used by
pathologist, radiologist, and pulmonologist is based on mor-
phology and was described by Reid (3) into cylindrical
bronchiectasis, varicose bronchiectasis, and saccular (cystic)
bronchiectasis (3–5).
Characteristically, most patients with bronchiectasis have
an obstructive pulmonary function defect (6). Forced expira-
tory volume in the first second (FEV1) values in patients with
bronchiectasis declines more rapidly and is used as a prognos-
tic marker (7). Table 1 summarizes the severity of an obstruc-
tive pulmonary function defect (8).
Multidetector-row computed tomography (MDCT) has the
ability to acquire contiguous high-resolution computed tomo-
graphy (HRCT) images throughout the thorax permitting a
global high-resolution assessment of the airways (9). Reforma-
tions and reconstructions are the easiest to generate and permit
creation of images oriented in any plane, especially along the
long axis of any airway (e.g. in coronal, sagittal and coronal
oblique orientation for the trachea and bronchi). Also various
2D and 3D reconstructions are provided including maximum
intensity projection (MIP), minimum intensity projection
(MinIP), Volume rendered (VR) and virtual bronchoscopy
(10,11).
1.1. Aim of the work
The aim of this study was to assess whether there is a correla-
tion between MDCT severity score of bronchiectasis and pul-
monary function tests.
2. Patients and methods
The current study included 20 patients presented with clinically
or CT known bronchiectasis. They included 8 males (40%) and
12 females (60%), and their ages ranged between 19 and
69 years with a mean age of 48.35 years.Table 1 Distribution of patients as regards individual and total CT
Score Case no.
1 2 3 4 5 6
Score of severity of bronchial dilatation 3 3 2 3 3 3
Score of bronchial wall thickening 2 2 1 2 3 2
Score of extent of bronchiectasis 2 3 2 2 3 3
Score of extent of mucous plugging 0 0 0 0 1 0
Score of generation of bronchial divisions 3 3 2 3 3 2
Score of mosaic attenuation pattern 0 2 1 1 2 1
Final CT score 10 13 8 11 15 11
CT score severity M M Mi M S M
Mi =Mild, M=Moderate, S = Severe.
A score of 0 indicated a normal Bhalla score.
A score of 1–9, a mild Bhalla score.
A score of 10–14, a moderate Bhalla score.
A score of 15–18, a severe Bhalla score.This study was approved by the board of medical ethics
committee in our faculty and all patients were aware of the
examination and patient written agreement was obtained.
All patients were subjected to full history taking, thorough
clinical examination, conventional chest X-ray study and
multi-detector chest computed tomography (MDCT)
imaging.
The MDCT examinations were done on Philips Brilliant
16-slice CT and Philips Brilliant 64-slice CT. Scanning param-
eters were as follows: Volumetric high-spatial-frequency algo-
rithm; slice thickness: 1.25 mm; table speed for volumetric
HRCT to enable the least cycles of breath-holds as possible;
tube rotation: 0.6–0.9 s (0.75 s); Detector Collimation: 1 mm;
field of view (FOV) for small, medium and large patients;
KVp and mA per slice: 120 kVp and approximately 6 240 mA.
For adequate multiplanar reconstruction, scans were per-
formed to cover the root of the neck down to the level of the
adrenal glands. Intravenous non-ionic contrast (ULTRA-
VIST Iopromide-Bayerimaging) was given in 17 patients,
and three patients were examined without contrast due to their
impaired renal function.
The acquired images were sent to highly specialized work-
station (Advantage-Workstation 4.2. GE Healthcare), where
the axial source images were analyzed. Then different 2D
and 3D reconstructions are obtained. Multi-planar reconstruc-
tion of the acquired thin sliced axial images facilitated not only
coronal and sagittal viewing but also oblique views in certain
circumstances to trace a bronchus in question, or straighten
tortuous vessel. MIP rendered views easily differentiate differ-
ent patterns and distribution of pulmonary nodules. MinIP
rendered views were also practical in better appreciation of
the airway diseases. Volume rendered VR and virtual bron-
choscopy techniques allow accessory view of airways in some
cases.
Each CT examination was evaluated for the presence of
bronchiectasis with subsequent analysis of the type (cylindri-
cal, varicose, and cystic) and distribution of bronchial disease.
A similar analysis using a modification of the Bhalla scoring
system that was applied in cases of cystic fibrosis (12) including
determination of the severity of bronchial dilatation, extent of
bronchiectasis, extent of mucous plugging and generations of
bronchial divisions included as well as the degree of mosaicscore of bronchiectasis and severity of the total CT score.
7 8 9 10 11 12 13 14 15 16 17 18 19 20
3 2 1 3 3 2 3 3 3 3 2 3 2 3
2 1 1 1 2 2 3 1 2 2 1 1 1 1
2 2 1 1 3 1 3 1 3 3 1 2 1 2
0 0 0 0 1 1 2 0 0 0 0 0 1 0
3 2 2 3 3 2 3 3 3 3 3 3 3 2
1 0 0 2 3 2 3 1 1 0 2 1 0 1
11 7 5 10 15 10 17 9 12 11 9 10 8 9
M Mi Mi M S M S Mi M M Mi M Mi Mi
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lobe as following.
The average severity score of bronchial dilatation was
quantified relative to the adjacent pulmonary artery as follows:
0 = none, 1 = 100–200% arterial diameter; 2 = 200–300%
arterial diameter; 3 =>300% arterial diameter.
The average severity score of the extent of bronchiectasis,
extent of mucous plugging and extent of mosaic attenuation
were quantified as follows: 0 = none, 1 when 1–5 bronchopul-
monary segments were involved, 2 when 6–9 bronchopul-
monary segments were involved and 3 when more than 9
bronchopulmonary segments were involved.
The quantification score of generations of bronchial divi-
sions included was done as following: 0 = none, 1 when up
to the 4th bronchial generation were involved, 2 when up to
the 5th bronchial generation were involved and 3 when up to
the 6th bronchial generation or distal were involved.
Bronchial wall thickness score was quantified relative to the
adjacent pulmonary arteries as follows: 0 = none; 1 =<50%
arterial diameter; 2 = 50–100% arterial diameter;
3 =>100% arterial diameter (13).
We ignored the items of emphysema, consolidations or col-
lapse and bullae from our modification of Bhalla scoring sys-
tem because these items represent more or less parenchymal
changes rather than airway changes. The total CT score was
considered mild if it ranges between 1 and 9, moderate if it
ranges between 10 and 14 and severe if it ranged 15–18.
Relative pulmonary function tests were done in an interval
not exceeding one week either before or after CT examination.
The functional indices measured by spirometry were forced
expiratory volume in one second (FEV1), forced vital capacity
(FVC) and FEV1/FVC, and these were expressed as percent-
ages of values predicted for the patient’s age, sex and height.
Forced expiratory volume in one second (FEV1) was sepa-
rately input as a marker of disease severity as follows:
Mild = FEV1P 80% predicted, moderate = 50%P
FEV1 < 80% predicted, severe = 30%P FEV1 < 50% pre-
dicted and very severe FEV1 < 30% predicted or
FEV1 < 50% predicted plus chronic respiratory failure.Fig. 1 19 years old female with kartagener syndrome. CT revealed mi
airway obstruction with predicted FEV1 of 85.2%: (a) axial CT scan s
medial segment of left middle lobe with medial segment collapse (inver
changes and collapse of medial segment of left middle lobe.All the obtained data were analyzed using SPSS (Statistical
Package for the Social Science) software for windows (version
18.0) using Chi-square test.3. Results
The most common clinical presentation was cough in all
patients (100%), in 17 of them (85%) it was productive cough,
dyspnea in 13 patients (65%), and chest pain in 11 patients
(55%), followed by hemoptysis in 3 patients (15%). The etiolo-
gies of bronchiectasis included non-specific post infectious in
13 cases (65%), TB in five cases (25%), Kartagener syndrome
in one case (5%) and focal endobronchial obstruction in one
case (5%).
The right lower lobe and right middle lobe were involved in
14 patients, followed by the left lower lobe which was involved
in 12 patients (60%), and then the right upper lobe and the left
upper lobe which were involved in 11 patients (55%) followed
by lingula which was involved in 10 patients (50%) for each
lobe.
In the present study, bilateral lung involvement was the
commonest with sparing of the right lung in one patient and
the left in 5 patients.
The distribution of patients as regards the severity of indi-
vidual and total CT score of bronchiectasis is shown in Table 1.
35% of patients were categorized as mild (Fig. 1), 50% as
moderate (Figs. 2 and 3) and 15% as severe (Figs. 4 and 5)
according to the total CT score of severity of bronchiectasis.
The performed pulmonary function test severity marker
revealed that 20% of patients were categorized as severe pul-
monary obstructive disease, 30% of patients were categorized
as moderate pulmonary obstructive disease and 50% patients
were diagnosed as mild pulmonary obstructive disease.
There was a significant relationship between the severity of
bronchial wall thickness in relation to FEV1 severity is (p value
of 0.031) i.e. the more severe bronchial wall thickness, the
more the deterioration in the pulmonary functions was
(Table 2).ld CT score severity of bronchiectasis and spirometry revealed mild
hows cylindrical bronchiectasis involving the right lower lobe and
ted lung lobes anatomy) and (b) sagittal mIP shows bronchiectatic
Fig. 2 56 years old female patient presented with productive cough, chest pain and hemoptysis. CT revealed moderate CT score severity
of bronchiectasis: (a) axial CT scans show cystic bronchiectasis involving upper, middle and lower right lung lobes (arrows) with grape-like
clusters of cystic bronchiectasis of grade 3 bronchial dilatation, (b) MIP CT reconstruction shows tree in bud nodules reflecting trans
bronchial spread of infection, (c) spirometry curve revealed moderate airway function compromise with predicted FEV1 of 68.9%.
Fig. 3 41 years old female presented with productive cough and dyspnea, CT revealed moderate CT score severity of bronchiectasis:
(a, b & c) axial lung window CT images show cystic bronchiectatic changes involving mainly RUL, and medial segment of LLL with grade
3 bronchial dilatation and associated with grade 1 mosaic attenuation pattern, (d) spirometry curve revealed mild air way function
compromise with predicted FEV1 of 82.6%.
416 R.M. Ibrahim et al.There was a significant relationship between the severity of
the extent of bronchiectasis in relation to FEV1 severity (p
value of 0.023) (Table 3).
There was a significant relationship between the severity of
mosaic attenuation pattern (decreased lung attenuation) in
relation to FEV1 (p value of 0.036), and the more severe
mosaic attenuation pattern was associated with more deterio-
ration in pulmonary functions (Table 4).
On the other hand there was no statistically significant rela-
tionship between the severity of bronchial dilatation and FEV1
(p value of 0.655) (Table 5). Also there was no statistically sig-
nificant relationship between the extent of mucous plugging in
relation to FEV1 severity (p value of 0.091) (Table 6).The severity of the total CT score of bronchiectasis in
relation to FEV1 severity is demonstrated in Table 7 with p
value of 0.032 denoting a significant relationship between CT
score of bronchiectasis and the deterioration in pulmonary
function.
4. Discussion
Chest radiography is usually the first imaging study performed
in patients with suspected bronchiectasis (14). Before the intro-
duction of CT, bronchography was the method of choice for
diagnosis and assessment of bronchiectasis, and then largely
replaced by high-resolution CT (15,16). The introduction of
Fig. 4 30 years old diabetic male patient presented with purulent productive cough, dyspnea and chest pain. CT revealed severe CT score
of bronchiectasis: (a, b and c) axial CT scans show bilateral varicose bronchiectasis involving all lung lobes (grade 3 bronchiectasis
extension) more in both lower lobes, some with fluid filled bronchi with grade 3 bronchial dilatation. Mosaic attenuation was also noted
(arrow in d), (e) axial CT cut showing mucous plugging (arrows), (f) spirometry curve revealed severe airway function compromise with
predicted FEV1 of 32.2%.
Fig. 5 56 years old male patient known with TB presented with cough, dyspnea, chest pain and blood streaked sputum. CT revealed
severe CT score of bronchiectasis: (a and b) axial CT scans show cylindrical and varicose bronchiectasis involving mainly LUL (arrows in
a and b) associated with bilateral apical pleural thickening and cavitations, with both hyper inflated lung fields and multiple paraseptal
bullae (curved arrow in a), (c) shows grade 3 peribronchial thickening with total and near total bronchial obliteration (arrows), (d) shows
tree in bud nodules (arrow) reflecting transbronchial spread of infection, (e) coronal CT scan shows failure of tapering sign with
peribronchial thickening, (f) spirometry curve revealed severe airway function obstruction with predicted FEV1 of 48.1%.
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Table 2 Severity of bronchial wall thickening in relation to
FEV1 severity.
Bronchial wall thickening FEV1 severity Total
Mild Moderate Severe
Mild No 6 3 0 9
% 60.0% 50% 0% 45%
Moderate No 4 3 2 9
% 40.0% 50.0% 50% 45%
Severe No 0 0 2 2




* Statistically significant 6 0.05.
Table 3 Severity of the extent of bronchiectasis in relation to
FEV1 severity.
Extent of bronchiectasis FEV1 severity Total
Mild Moderate Severe
Mild No 5 1 0 6
% 50.0% 16.7% 0% 30.0%
Moderate No 4 3 0 7
% 40.0% 50.0% 0% 35.0%
Severe No 1 2 4 7




* Statistically significant 6 0.05.
Table 4 Mosaic attenuation severity in relation to FEV1
severity.
Mosaic attenuation FEV1 severity Total
Mild Moderate Severe
Absent No 4 0 1 5
% 40% 0% 25% 25%
Mild No 5 3 0 8
% 50.0% 50% 0% 40%
Moderate No 1 3 2 6
% 10% 50% 50% 30%
Severe No 0 0 1 1




* Statistically significant 6 0.05.






Mild No 1 0 0 1
% 10.0% 0% 0% 5.0%
Moderate No 4 1 1 6
% 40.0% 16.7% 25.0% 30.0%
Severe No 5 5 3 13




*Statistically significant 6 0.05.
Table 6 Extent of mucous plugging in relation to FEV1
severity.
Extent of mucous plugging FEV1 severity Total
Mild Moderate Severe
Absent No 9 5 1 15
% 90.0% 83.3% 25.0% 75.0%
Mild No 1 1 2 4
% 10.0% 16.7% 50.0% 20.0%
Moderate No 0 0 1 1




*Statistically significant 6 0.05.
Table 7 Severity of total CT score of bronchiectasis in
relation to FEV1 severity.
CT score severity FEV1 severity Total
Mild Moderate Severe
Mild No 6 1 0 7
% 60.0% 16.7% 0% 35.0%
Moderate No 4 4 2 10
% 40.0% 66.7% 50.0% 50.0%
Severe No 0 1 2 3
% 0% 16.7% 50.0% 15.0%
Total No 10 6 4 20




* Statistically significant 6 0.05.
418 R.M. Ibrahim et al.multi-detector CT has provided the radiologist with a powerful
new tool for the diagnosis of bronchiectasis (9).
In this study the most common type of bronchiectasis
detected was the cystic type which was seen in 11 patients
(55%) followed by the cylindrical type in 5 patients (25%)and varicose type in four patients (20%), and the cystic type
was associated with more severe lung functional impairment
and worse CT scoring and has the most frequent development
of pulmonary hypertension as compared with cylindrical and
varicose types.
A proposed MDCT severity score of bronchiectasis and pulmonary function tests 419These findings were consistent with those given by Lynch
et al. (17) who reported that patients with cystic bronchiectasis
had significantly lower FEV1 values than patients with cylin-
drical or varicose bronchiectasis, and also Alzeer (18) reported
that the cystic type was the most common type and the worst
in lung functional impairment and CT scoring.
In our study, spirometry revealed 10 patients (50%) with
mild airway obstruction, 6 patients (30%) with moderate air-
way obstruction and 4 patients (20%) with severe airway
obstruction. Those results were consistent with those reported
by King et al. (19), Pasteur et al. (20), and Martinaz et al. (21)
who reported mild obstructive type spirometric abnormality in
most of their patients.
Although this study includes only 20 patients, there was a
good correlation between final scores achieved with CT scoring
system of bronchiectasis and PFT results represented by
FEV1.
The CT morphologic changes of bronchiectasis that corre-
late with the severity of FEV1 were the extent of bronchiecta-
sis, severity of bronchial wall thickening and mosaic
attenuation pattern (the extent of decreased lung parenchyma
attenuation) respectively.
The severity of bronchial dilatation, generations of bron-
chial divisions involved and the extent of mucous plugging
were not major determinants of airflow obstruction in our
study.
These findings indicate that airflow obstruction in
bronchiectasis in our study is primarily linked to severity of
extent of bronchiectasis, severity of bronchial wall thickening
and the degree of mosaic attenuation.
De Jong et al. (22) reported in their study which aimed for
the assessment of pulmonary disease in cystic fibrosis that
there was a highly significant correlation between CT scores
and the results of pulmonary function tests (PFTs) such as
FEV1 forced expiratory volume in 1 s (FEV1).
Our findings were consistent with results found by Roberts
et al. (23) who reported in their study that there were signifi-
cant correlations between FEV1 and the extent of bronchiecta-
sis, the severity of bronchiectasis, the severity of bronchial wall
thickening, and the extent of decreased attenuation; they
reported that the major morphologic determinants of func-
tional impairment were bronchial wall thickness and decreased
attenuation, which were largely related to the severity of air-
flow obstruction, and they also reported that the increasingly
severe bronchial dilatation was consistently associated with
less severe airflow obstruction and also the plugging in small
and large airways was not independently related to the severity
of airflow obstruction.
Mehmet et al. (24) reported that there was a significant cor-
relation between the extent of bronchiectasis, the degree of
bronchial dilatation, bronchial wall thickening, decreased
attenuation in lung parenchyma, and PFT parameters in
patients with pure bronchiectasis. Conversely, the presence of
mucus plugging in airways (large and small) was found to have
less effect on PFT results, and the extent of bronchiectasis and
decreased attenuation in the lung parenchyma were the main
determinants of the reduction of PFT parameters. These find-
ings suggest that the morphologic changes in patients with
pure bronchiectasis could lead to both restrictive and obstruc-
tive functional impairments.
The increased extent of bronchiectasis reflects the extent of
inflammation and destruction in airways, and thus a propor-tional impairment of pulmonary function could be expected.
The restrictive component of impairment in lung function
can be explained by atelectasis, pleural disease, parenchymal
scarring, and peribronchial fibrosis that accompany
bronchiectasis.
The decrease of attenuation in the pulmonary parenchyma
that surrounds the bronchiectatic bronchi implies an associa-
tion of bronchiectasis with obliterative bronchiolitis, and it
can be seen as a mosaic pattern radiologically. Reports have
shown that obliterative bronchiolitis that is accompanied by
bronchiectasis is one of the primary causes of the obstructive
type of pulmonary function impairment (23,25,26).
Moreover, obliterative bronchitis is considered by some
authors to be a part of bronchiectasis, and it is an early finding
in the pathogenesis of the disease. Hansell et al. (27) contend
that monitoring the attenuation decrease in the pulmonary
lobes, which have no sign of bronchiectasis in patients with
bronchiectasis, supports this view. Also the strong association
between increasing bronchial wall thickness on the inspiratory
CT scan and decreased attenuation is further supportive evi-
dence of underlying bronchiolitis (23).
Shah et al. (28) suggested that the presence of mucus plug-
ging in large and small airways in patients with cystic fibrosis
did not affect pulmonary function. Mehmet et al. (24) study
also revealed that the presence of mucus plugging in airways
of patients with bronchiectasis was not the primary cause of
lung function impairment. However, as stated by Sheehan
et al. (26) when the mucus load of airways varies over time this
could be a reason for some fluctuation in pulmonary function.
Patients with bronchiectasis usually have mild to moderate
airflow obstruction and over time develop progressively wors-
ening airflow obstruction (29,30). This may be surprising as the
cardinal feature of bronchiectasis is airway dilatation. This
paradox can be explained by the pathology findings from
Whitwell’s study (5) which demonstrated that while the large
airways were dilated the small airways were obstructed; as
most of the pulmonary tree is composed of small airways the
net effect is obstruction.
A similar effect has also been demonstrated by Roberts
et al. (23); they reported that the most surprising finding in
their study was the strong independent association between
increasingly severe bronchial dilatation and lesser degrees of
airflow obstruction, and their study also showed that small air-
way constrictive bronchiolitis manifesting as a mosaic pattern
on CT was the primary feature associated with airflow
obstruction.
In the literature, contradictory results have been obtained
regarding the impact of the degree of bronchial dilatation on
pulmonary function in patients with bronchiectasis. Mehmet
et al. (24) reported that the degree of bronchial dilatation
was associated with a decrease of the FEV1/FVC ratio. Also
Lee et al. (31) reported that the degree of bronchial dilatation
correlated with airway obstruction.
Bronchial dilatation is one of the main signs of bronchiec-
tasis morphologically. It has been previously shown that small
airway disease correlates with bronchial dilatation in patients
with bronchiectasis. In parallel with the increase of bronchial
dilatation in the patients with bronchiectasis, the increase in
airway obstruction can be associated with morphologic
changes in small airways (32).
Chooi et al. (33) reported that 3D imaging of the bronchi is
not used routinely in assessment of the airways as it is time
420 R.M. Ibrahim et al.consuming and unpractical in a busy department. However,
3D imaging offers useful information in cases with abnormal-
ities of the trachea and major bronchi.
5. Conclusion
There is significant correlation between our proposed MDCT
based severity scoring system and spirometric based severity
of pulmonary function deterioration.
Airflow obstruction in bronchiectasis is significantly linked
to total severity scoring of bronchiectasis, bronchial wall
thickening and the degree of mosaic attenuation.
On the other hand there was no statistically significant
relationship between the severity of bronchial dilatation and
airflow obstruction.
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